Institutional Ownership Y M Abs Therapeutics, Inc. (YMAB)
This table provides information about the institutional ownership of Y M Abs Therapeutics, Inc. (YMAB). We have compiled data on the 113 institutions that hold shares in the stock, with a total of 26.9 Million shares, which have been reported (via 13F filing form) to have a value of $173 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,236,346
shares
|
$25.6 Million
1.27% of portfolio
|
Q4 2024
Added 3.67%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,938,718
shares
|
$17.7 Million
0.0% of portfolio
|
Q2 2024
Added 2.85%
|
|
Acorn Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,861,825
shares
|
$17.3 Million
12.11% of portfolio
|
Q4 2024
New holding
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
2,194,278
shares
|
$13.3 Million
1.4% of portfolio
|
Q4 2019
Added 4.28%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,000,022
shares
|
$12.1 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.74%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,831,000
shares
|
$11.1 Million
0.09% of portfolio
|
Q1 2024
Reduced 10.98%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,314,409
shares
|
$7.94 Million
0.0% of portfolio
|
Q4 2024
Added 8.65%
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$6.04 Million
1.03% of portfolio
|
Q4 2024
Added 25.0%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
822,309
shares
|
$4.97 Million
0.0% of portfolio
|
Q4 2024
Added 1.08%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
756,297
shares
|
$4.57 Million
0.01% of portfolio
|
Q4 2024
Added 9.93%
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
693,693
shares
|
$4.19 Million
0.17% of portfolio
|
Q4 2024
Added 24.45%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
615,131
shares
|
$3.72 Million
0.0% of portfolio
|
Q4 2024
Reduced 21.89%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
463,235
shares
|
$2.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.02%
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
425,000
shares
|
$2.57 Million
0.26% of portfolio
|
Q4 2024
Reduced 70.69%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
359,223
shares
|
$2.17 Million
0.0% of portfolio
|
Q4 2024
Added 6.5%
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
349,982
shares
|
$2.11 Million
0.19% of portfolio
|
Q4 2024
Reduced 12.5%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
320,807
shares
|
$1.94 Million
0.0% of portfolio
|
Q4 2024
Added 28.98%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
284,540
shares
|
$1.72 Million
0.0% of portfolio
|
Q4 2024
Added 1.78%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
221,914
shares
|
$1.34 Million
0.0% of portfolio
|
Q4 2024
Reduced 19.17%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
219,175
shares
|
$1.32 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.54%
|
|
Memorial Sloan Kettering Cancer Center
New York, NY |
Nov 14, 2023 Q3 2023 |
191,176
shares
|
$1.15 Million
4.24% of portfolio
|
Q4 2021
Reduced 11.87%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
149,681
shares
|
$904,073
0.0% of portfolio
|
Q2 2024
Reduced 2.81%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
133,263
shares
|
$804,908
0.0% of portfolio
|
Q4 2024
Reduced 2.52%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
131,600
shares
|
$794,864
0.0% of portfolio
|
Q4 2024
Added 371.68%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
127,159
shares
|
$768,040
0.0% of portfolio
|
Q4 2024
Added 59.51%
|